Multimorbidity and oral health: need for new models of care

Balraj Gill, Andrew Harris, Christopher Tredwin, Paramjit Gill

ABSTRACT Multimorbidity is defined as patients living with two or more chronic health conditions. The prevalence of multimorbidity is increasing, driven by the ageing population, and represents a major challenge to all healthcare systems because these patients are heavy users of services. The link with oral health is growing although there is need for further robust evidence. There is also need for new models of care to address oral health in patients with multimorbidity.

INTRODUCTION

Multimorbidity is generating increasing interest; it has not been uniformly defined in the past and we have adopted the Academy of Medical Sciences definition ‘…the coexistence of two or more chronic conditions in the same individual.’1As worldwide mortality rates decrease combined with an ageing population, the number of people affected by multimorbidity has increased dramatically.2The prevalence of morbidity increases with age with and deprivation with people in deprived areas having the same prevalence of multimorbidity as more affluent patients who were 10–15 years older.13

Expenditure on healthcare rises almost exponentially with the number of chronic disorders that an individual has, so increasing multimorbidity generates financial pressures. This economic burden heightens the need to manage people with several chronic illnesses in more efficient ways.45

In a systematic analysis of global burden,6oral conditions were deemed endemic, affecting 3.9 billion people worldwide. Despite being largely preventable, dental caries was found to have the highest prevalence (35% globally) of the 291 included conditions; severe periodontitis, and severe tooth loss were sixth, and thirty- sixth, respectively, while oral cancer is the eleventh most common malignancy worldwide.7

Perhaps unsurprisingly, WHO considers oral conditions a major public health problem;8inextricably linked to overall health, poor oral health can lead to infection and pain and can have a subtle effect on well- being such as sleep, work and social confidence.9While oral health conditions are not primarily viewed as life-threatening conditions,10those with poor oral health have a significant association with higher mortality.11

While oral conditions often have shared risk factors with other chronic conditions, it has been hypothesised that oral diseases, such as periodontitis, may contribute to a proinflammatory state.12This may play a part in accelerating or exacerbating conditions related to chronic conditions, such as cardiovascular disease, which in 2016 accounted for 17.9 million deaths globally.1314

ASSOCIATION BETWEEN ORAL HEALTH AND GENERAL HEALTH

For the past three decades there has been and increasing focus on the relationship between oral disease and other commonly found medical diseases. The majority of the literature has focused on periodontitis15and its relationship with other systemic inflammatory diseases, although no cause-effect relationships have been widely accepted.16

Disentangling a cause- effect relationship from shared risk factors has been problematic due to study design challenges, though indirect evidence suggests an independent relationship between periodontal disease and conditions such as type 2 diabetes, rheumatoid arthritis, cardiovascular disease, Parkinson’s disease, psoriasis, respiratory infections and Alzheimer’s disease, among others.16

There continues to be emerging evidence that oral health plays a role in general chronic diseases. In particular, periodontal disease and diabetes mellitus have been described as having a ‘bi- directional’ relationship, meaning glycaemic control affects a person’s periodontal status, and vice versa. Studies have shown that people with diabetes who have severe gum disease—characterised as bleeding gums, gingival recession, tooth mobility and alveolar bone loss—also have higher HbA1c levels compared with those with healthier gums.17One study indicated that non- surgical periodontal treatment significantly improved metabolic control in patients with type 2 diabetes.18Conversely, raised levels of advanced glycation end products in patients with poorly controlled diabetes may result in production of proinflammatory cytokines. These cytokines in turn can induce periodontal tissue destruction.19

Indeed, periodontal disease has been shown to have associations with many other diseases. These include increased risk of heart attack or stroke, independent of the other well- known cardiovascular risk factors. Indirect mechanisms such as systemic inflammation have been proposed, with increased levels of inflammatory protein as found in patients with periodontitis, also being predictors of future cardiac events.20It has also been suggested that direct mechanisms such as bacteraemia and vascular infection from periodontal pathogensmay contribute to aortic vasculopathy.21A direct cause- effect relationship was suggested in a PAROKRANK Study22and a significant risk of first- time myocardial infarction was found in patients with periodontitis, this risk remaining significant even after adjustments were made for risk factors such as smoking and diabetes. The expectation that periodontal treatment would therefore reduce the risk of cardiovascular events has not materialised however, with little evidence found in a recent umbrella review that non- surgical therapy reduces the risk of cardiovascular events.23

Furthermore, in some at- risk populations, poor oral health and periodontitis may be associated with certain respiratory conditions including pneumonia and chronic obstructive pulmonary disease (COPD). Typical respiratory pathogens have been shown to colonise the dental plaque of hospitalised intensive care and nursing home patients24and it has been suggested that these pathogens may then become aspirated into the lungs and cause infection. One study reported that alveolar bone loss was an independent risk factor for COPD, supporting a possible role of periodontal disease in the pathogenesis of COPD or its progression.25

Further, maternal periodontal disease and low birth weight of infants has been shown to have an association.9Once again, it has been postulated that bacterial migration from periodontal tissues into blood circulation may stimulate the production of inflammatory mediators.

RISK FACTORS

One of the greatest risk factors is age- related deterioration of the oral tissues and a higher probability of systemic illness.26As populations age, maintaining oral care becomes problematic and gingival recession and root caries becomes more prevalent.27It has been estimated that in India almost half of those aged 75 years have an experience of root caries,28which is a major cause of tooth loss.27In the USA tooth loss increases with age and almost 19% of seniors (over 65 years) are edentulous.29

Tooth loss has a significant effect on well-being, and has been related to a decline in nutrition and health, as food preferences move away from fresh vegetables and fruits towards softer foods.29Further, edentulous patients who retain their dental prosthesis overnight have increased risk of pneumonia.30

The decline in oral health in an ageing population has been linked to the side effects of polypharmacy related to chronic conditions. A plethora of commonly prescribed medications can induce hyposalivation, which increases the risk of oral disease including caries, periodontal disease and candidiasis.31

Certain chronic conditions which are more prevalent in the elderly can lead to a reduction in cognitive or motor skills. Patients with dementia can be reluctant to remove their dentures at night, which can lead to denture stomatitis. Additionally other progressive neurological disorders such as Parkinson’s disease can affect motor function and has been associated with a greater risk of caries and periodontal disease.26

Risk factors are not confined to an ageing population and the burden is greatest on those from low socioeconomic backgrounds, not least because WHO says treatment of oral disease is costly, the fourth most expensive disease to treat in many countries.8

Stress, hygiene and trauma as well as the more common risk factors like unhealthy diet, smoking and alcohol consumption have been implicated32; therefore oral health improvement is not just in its treatment, but also prevention. However, in developing countries where oral health expenditure is already low, resources are largely focused on treatment of acute symptoms and emergency care. It is estimated that if treatment and preventative measures were widely available, the cost of dental caries for children alone would exceed total child healthcare expenditure.33As a consequence, in many countries there are a number of difficulties in overcoming untreated dental disease.

In terms of risk factors, many are shared between oral and general chronic problems like diabetes and cardiovascular disease. These common modifiable factors usually relate to lifestyle habits. It is a well- established fact that smoking cigarettes increases the risk of lung cancer, but it also increases the risk of tooth loss as a result of periodontal disease.34Therefore, there is an association between oral diseases and non- communicable diseases and by addressing these factors, the positive impact on the population would be significant.

CONCLUSION

It appears that many populations globally are experiencing multimorbidity and the available evidence about the burden, determinants, prevention and treatment of patients with multimorbidity is inadequate. Research gaps need to be filled across a wide range of perspectives from biological mechanisms to healthcare systems management.1

In the meantime, implementation of public health measures in order to reduce exposure to risk factors is key in reducing the burden of oral disease, and at the same time general diseases. It is likely that health inequalities must be addressed in order for factors like sugar consumption, alcohol and smoking use to decrease.31In terms of dental conditions, the disease process is largely avoidable, and as such prevention should be at the forefront of tackling this issue. This needs coordination and delivery by all health professionals as well as statutory and third sector organisations.

ContributorsPG and BG conceived the idea that was developed by all the authors. BG wrote the first draft with critical inputs from PG, AH, CT.

FundingThe authors have not declared a specific grant for this research from any funding agency in the public, commercial or not- for- profit sectors.

Competing interestsNone declared.

Patient consent for publicationNot required.

Provenance and peer reviewNot commissioned; externally peer reviewed.

Open accessThis is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY- NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non- commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non- commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.